Semapimod
Semapimod, an inhibitor of proinflammatory cytokine production, can inhibit TNF-α, IL-1β, and IL-6. Semapimod inhibits TLR4 signaling (IC50≈0.3 μM) . Semapimod inhibits p38 MAPK and nitric oxide production in macrophages. Semapimod has potential in a variety of inflammatory and autoimmune disorders[1][2][3].
Product Specifications
CAS Number
352513-83-8
Product Name Alternative
CNI-1493 (free base) ; CPSI-2364
UNSPSC
12352005
Target
Interleukin Related; p38 MAPK; TNF Receptor
Type
Reference compound
Related Pathways
Apoptosis; Immunology/Inflammation; MAPK/ERK Pathway
Applications
COVID-19-immunoregulation
Field of Research
Cancer; Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/semapimod.html
Solubility
10 mM in DMSO
Smiles
O=C(NC1=CC(/C(C)=N/NC(N)=N)=CC(/C(C)=N/NC(N)=N)=C1)CCCCCCCCC(NC2=CC(/C(C)=N/NC(N)=N)=CC(/C(C)=N/NC(N)=N)=C2)=O
Molecular Formula
C34H52N18O2
Molecular Weight
744.90
References & Citations
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
Phase 2
Isoform
IL-1; IL-6; p38 MAPK; TNFRSF5/CD40
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
